Acidophilus and other probiotics. EBSCO Natural and Alternative Treatments website. Available at:
http://www.ebscohost.com/thisTopic.php?marketID=15topicID=114
. Updated June 2008. Accessed July 15, 2008.
Conn HF, Rakel RE.
Conn's Current Therapy
. Philadelphia, PA: WB Saunders Co; 2001.
Drossman DA.
Treatment for bacterial overgrowth in the irritable bowel syndrome.
Ann Intern Med
. 2006;145:626-628.
Griffith HW.
Griffith's 5-Minute Clinical Consult
. Baltimore, MD: Lippincott Williams Wilkins; 1999.
Halvorson HA, Schlett CD, Riddle MS.
Postinfectious irritable bowel syndrome—a meta-analysis.
Am J Gastroenterol
. 2006;101:1894-1899.
Irritable bowel syndrome.
American Society of Colon and Rectal Surgeons website. Available at:
http://www.fascrs.org/
Update October 2007. Accessed July 15, 2008.
Irritable bowel syndrome. EBSCO DynaMed website. Available at:
http://www.ebscohost.com/dynamed/what.php
. Updated December 2008. Accessed January 6, 2009.
Irritable bowel syndrome (IBS). EBSCO Health Library website. Available at:
http://www.ebscohost.com/thisTopic.php?marketID=15topicID=81
. Updated July 2008. Accessed July 7, 2008.
Irritable bowel syndrome.
National Institute of Diabetes and Digestive and Kidney Diseases website. Available at:
http://www.niddk.nih.gov/
. Update September 2007. Accessed July 15, 2008.
Murch S. Allergy and intestinal dysmotility—evidence of genuine causal linkage?
Curr Opin Gastroenterol
. 2006;22:664-668.
Rubin G, De Wit N, Meineche-Schmidt V, Seifert B, Hall N, Hungin P.
The diagnosis of IBS in primary care: consensus development using nominal group technique.
Family Practitioner
. 2006;23:687-692.
Sleisenger MH, Fordtran JS, Feldman M, Scharschmidt B.
Sleisenger Fordtran's Gastrointestinal and Liver Disease
. 6th ed. Philadelphia, PA: WB Saunders Co; 1998.
Talley NJ, Boyce PM, Jones M. Is the association between irritable bowel syndrome and abuse explained by neuroticism? A population based study.
Gut.
1998;42: 47-53.
Yan F, Polk DB. Probiotics as functional food in the treatment of diarrhea.
Current Opinion in Clinical Nutrition and Metabolic Care
. 2006;9:717-721.
*¹9/26/2006 DynaMed's Systematic Literature Surveillance
DynaMed's Systematic Literature Surveillance
: Mueller-Lissner S, Tytgat GN, Paulo LG, et al. Placebo-and paracetamol-controlled study on the efficacy and tolerability of hyoscine butylbromide in the treatment of patients with recurrent crampy abdominal pain.
Alimentary Pharmacology and Therapeutics
. 2006;23:1741-1748.
*²4/10/2007 DynaMed's Systematic Literature Surveillance
DynaMed's Systematic Literature Surveillance
: US Food and Drug Administration. FDA announces discontinued marketing of GI drug, Zelnorm, for safety reasons [press release]. March 30, 2007. US Food and Drug Administration website. Available at:
http://www.fda.gov/bbs/topics/NEWS/2007/NEW01597.html.
*³1/6/2009 DynaMed's Systematic Literature Surveillance
DynaMed's Systematic Literature Surveillance
: Ford AC, Talley NJ, Spiegel BM, et al. Effect of fibre, antispasmodics, and peppermint oil in the treatment of irritable bowel syndrome: systematic review and meta-analysis.
BMJ.
2008;337:a2313.
Please be aware that this information is provided to supplement the care
provided by your physician. It is neither intended nor implied to be a
substitute for professional medical advice. CALL YOUR HEALTHCARE PROVIDER
IMMEDIATELY IF YOU THINK YOU MAY HAVE A MEDICAL EMERGENCY. Always seek the
advice of your physician or other qualified health provider prior to
starting any new treatment or with any questions you may have regarding a
medical condition.
Copyright © 2004 EBSCO Publishing All rights reserved.